Back

Identification of small molecule enhancers of NK cell tumoricidal activity via a tumor microenvironment-mimicking co-culture assay

Binici, A.; Hennes, E.; Koska, S.; Niemann, J.; Reich, A.; Pfaff, C.; Sievers, S.; Kahnt, A.; Thomas, D.; Ziegler, S.; Watzl, C.; Waldmann, H.

2024-09-07 immunology
10.1101/2024.09.04.611205 bioRxiv
Show abstract

The tumor microenvironment (TME) is a pro-cancerous niche harboring immunosuppressive factors that are secreted by cancer cells and the surrounding cancer-supportive tissue, such as kynurenine, prostaglandin E2 and transforming growth factor {beta} (TGF{beta}). These factors dampen the activity of cytotoxic lymphocytes like natural killer (NK) cells, allowing evasion of immune cell-mediated killing. To identify small molecules that counteract the immunosuppressive effect of the TME and restore NK cell-mediated cytotoxicity, we developed a phenotypic co-culture assay of cancer cells and primary lymphocytes suitable for medium-throughput screening. We discovered small molecules that restore NK cell-mediated cytotoxicity through diverse mechanisms. The potent TGF{beta} type I receptor (TGF{beta}R-1) inhibitor, RepSox, stood out as superior to other TGF{beta}R-1 inhibitors due to its ability to abolish the effects of both inhibitory factors used in our setup. This mode of action goes beyond TGF{beta}R-1 inhibition and is related to the simultaneous abrogation of cyclooxygenase 1 (COX1) activity.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 0.2%
10.9%
2
Journal of Medicinal Chemistry
77 papers in training set
Top 0.2%
7.5%
3
iScience
1154 papers in training set
Top 2%
5.7%
4
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.1%
5.6%
5
Nature Communications
5641 papers in training set
Top 32%
4.2%
6
Scientific Reports
3612 papers in training set
Top 29%
3.5%
7
Cell Chemical Biology
94 papers in training set
Top 0.3%
3.4%
8
eLife
5828 papers in training set
Top 33%
3.3%
9
Cell Reports
1498 papers in training set
Top 14%
2.7%
10
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 21%
2.5%
11
ACS Chemical Biology
167 papers in training set
Top 1%
2.5%
50% of probability mass above
12
Frontiers in Immunology
638 papers in training set
Top 4%
2.5%
13
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.2%
2.2%
14
Pharmacological Research
18 papers in training set
Top 0.1%
2.2%
15
Communications Biology
993 papers in training set
Top 13%
1.8%
16
Advanced Science
286 papers in training set
Top 6%
1.4%
17
Cell Reports Medicine
153 papers in training set
Top 3%
1.2%
18
Theranostics
37 papers in training set
Top 0.6%
1.2%
19
Science Advances
1243 papers in training set
Top 26%
1.1%
20
Frontiers in Oncology
103 papers in training set
Top 3%
1.1%
21
eBioMedicine
183 papers in training set
Top 6%
0.9%
22
Cancer Immunology Research
35 papers in training set
Top 0.8%
0.9%
23
ACS Central Science
71 papers in training set
Top 1%
0.9%
24
Molecular Therapy Oncology
10 papers in training set
Top 0.2%
0.9%
25
European Journal of Immunology
60 papers in training set
Top 1%
0.9%
26
Journal of Controlled Release
44 papers in training set
Top 0.7%
0.9%
27
Science Signaling
65 papers in training set
Top 2%
0.6%
28
International Immunopharmacology
15 papers in training set
Top 0.4%
0.6%
29
Journal of the American Chemical Society
217 papers in training set
Top 3%
0.6%
30
Cell Communication and Signaling
51 papers in training set
Top 2%
0.6%